01-02-2003 | Ongoing Clinical Studies
Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab
Published in: Annals of Hematology | Issue 2/2003
Login to get access